Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1980 Oct 1;152(4):1121–1125. doi: 10.1084/jem.152.4.1121

Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens

PMCID: PMC2185969  PMID: 6775039

Abstract

The ability to introduce carefully controlled numbers of viable cells into the anterior chamber of mouse eyes made it possible to examine the interrelationship between presentation of antigens into the anteior chamber and into conventional body sites and their synergistic/antagonistic effects on the immune system. P815 mastocytoma (DBA/2; H-2d) cells are syngeneic with BALB/c hosts at the major histocompatibility locus, but differ at multiple minor histocompatibility loci. When P815 cells were injected subcutaneously, they were rejected by BALB/c recipients who became specifically immune. By contrast, when P815 cells were injected intracamerally, they grew progressively into massive intraocular tumors; moreover, these BALB/c hosts proved subsequently unable to reject subcutaneously injected P815 cells, and, more impressively, failed to reject DBA/2 skin allografts placed orthotopically. Minor histocompatibility antigens, presented first through the anterior chamber of mouse eyes, elicit a suppressive rather than an aggressive host immune response that protects cells that bear these antigens from a destructive alloimmune reaction at both intracameral and systemic sites.

Full Text

The Full Text of this article is available as a PDF (303.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker C. F., Billingham R. E. Immunologically privileged sites. Adv Immunol. 1977;25:1–54. [PubMed] [Google Scholar]
  2. Dennert G., Lennox E. S. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells. J Immunol. 1974 Nov;113(5):1553–1561. [PubMed] [Google Scholar]
  3. GREENE H. S. N. Heterologous transplantation of the Brown-Pearce tumors. Cancer Res. 1949 Dec;9(12):728-35, illust. [PubMed] [Google Scholar]
  4. Kaplan H. J., Streilein J. W. Do immunologically privileged sites require a functioning spleen? Nature. 1974 Oct 11;251(5475):553–554. doi: 10.1038/251553a0. [DOI] [PubMed] [Google Scholar]
  5. Kaplan H. J., Streilein J. W. Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J Immunol. 1977 Mar;118(3):809–814. [PubMed] [Google Scholar]
  6. Kaplan H. J., Streilein J. W. Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J Immunol. 1978 Mar;120(3):689–693. [PubMed] [Google Scholar]
  7. Rao D. S., Grogan J. B. Orthotopic skin graft survival in rats that have harbored skin implants in the anterior chamber of the eye. Transplantation. 1977 Nov;24(5):377–381. doi: 10.1097/00007890-197711000-00010. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES